Parkin modulates expression of HIF-1[alpha] and HIF-3[alpha] during hypoxia in gliobastoma-derived cell lines in vitro

• Published in: Cell and tissue research 2016-06, Vol.364 (3), p.465
• Main Authors: Maugeri, Grazia, D'Amico, Agata Grazia, Reitano, Rita, Saccone, Salvatore, Federico, Concetta, Cavallaro, Sebastiano, D'Agata, Velia
• Format: Article
• Language: English
• Subjects: Analysis; Brain diseases; Cells; Experiments; Genetic aspects; Genetic research; Gliomas; Hypoxia; Mutation; Tumors
• ISSN: 0302-766X; 1432-0878
• DOI: 10.1007/s00441-015-2340-3

Mutation of the Parkin gene causes an autosomal recessive juvenile-onset form of Parkinson's disease. However, recently, it has been also linked to a wide variety of malignancies, including glioblastoma multiforme (GBM). In this pathology, Parkin exhibits a tumor suppressor role by mitigating the proliferation rate in both in vitro and in vivo models. However, Parkin involvement in the hypoxic process has not as yet been investigated. GBM is the most common and aggressive primary brain tumor in adults and is characterized by hypoxic areas. The low oxygen supply causes the expression of hypoxia-inducible factors (HIFs) leading to an accumulation of pro-angiogenic factors and tumoral invasiveness. We assess the relationship between Parkin and two HIFs expressed during hypoxic conditions, namely HIF-1[alpha] and HIF-3[alpha]. Our data show that Parkin is downregulated under hypoxia and that it interferes with HIF expression based on cellular oxygen tension. These results suggest a role for the involvement of Parkin in GBM, although further studies will be needed to understand the mechanism by which it modulates HIF-1[alpha] and HIF-3[alpha] expression.